Basic Materials / Specialty ChemicalsTel Aviv
$901.20
+16.30 (+1.82%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 24%
FCF escenarios
weak_data · normalized FCF $12.5M · quality 40.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$963M
P/E
28.2x
↑EV/EBITDA
2639.7x
↑ROE
8.4%
↑Gross Margin
19.5%
↓Debt/Equity
0.77
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.4%
FCF CAGR
+2.8%
FCF margin
4.3%
FCF / Net income
0.82x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $291.2M · net income $15.2M · FCF $12.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $291.2M | $291.2M | $274.1M | $263.6M | $313.4M |
| Net Income | $15.2M | $15.2M | $24.4M | $21.5M | $28.6M |
| EBITDA | $36.7M | $36.7M | $43.2M | $39.5M | $46.6M |
| EPS | 0.14 | 0.14 | 0.23 | 0.19 | 0.26 |
| Gross Margin | 19.5% | 19.5% | 21.4% | 19.5% | 18.2% |
| Operating Margin | 10.0% | 10.0% | 12.8% | 11.4% | 11.6% |
| Net Margin | 5.2% | 5.2% | 8.9% | 8.2% | 9.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.77 | 0.77 | 0.56 | 0.44 | 0.72 |
| Current Ratio | 1.46 | 1.46 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $12.5M | $12.5M | $1.6M | $61.9M | $11.5M |
| Returns | |||||
| ROE | 8.4% | 8.4% | 13.8% | 13.4% | 17.3% |
| Valuation | |||||
| P/E | 28.16 | 28.16 | 5576.07 | 5499.49 | 3618.88 |
| EV/EBITDA | 2639.65 | 2639.65 | 3154.83 | 3000.38 | 2217.88 |
| P/B | 531.68 | 531.68 | 769.48 | 737.74 | 626.41 |
| Growth & Yield | |||||
| Revenue Growth | 6.3% | 6.3% | 4.0% | -15.9% | — |
| EPS Growth | -37.7% | -37.7% | 16.6% | -24.5% | — |
| Dividend Yield | 4.1% | 4.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
726.6%
EPS terminal req.
$79.97
Spread vs growth
-764.3%
5Y implied EPS CAGR
268.9%
EPS terminal req.
$96.76
Spread vs growth
-306.6%
10Y implied EPS CAGR
101.4%
EPS terminal req.
$155.83
Spread vs growth
-139.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-3.6%
Start / end P/E
4356.6x → 6454.1x
EPS bridge
0.23 → 0.14
Residual
-18.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.